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Abstract  
The effects of poly(D,L-lactic acid) macroporous guidance scaffolds (foams) with or without brain-derived 
neurotrophic factor (BDNF) on tissue sparing, neuronal survival, axonal regeneration, and behavioral 
improvements of the hindlimbs following implantation in the transected adult rat thoracic spinal cord were 
studied. The foams were embedded in fibrin glue containing acidic-fibroblast growth factor. One group of 
animals received fibrin glue with acidic-fibroblast growth factor only. The foams were prepared by a thermally 
induced polymer-solvent phase separation process and contained longitudinally oriented macropores connected 
to each other by a network of micropores. Both foams and fibrin only resulted in a similar gliotic and 
inflammatory response in the cord-implant interfaces. With BDNF foam, up to 20% more NeuN-positive cells in 
the spinal nervous tissue close to the rostral but not caudal spinal cord-implant interface survived than with 
control foam or fibrin only at 4 and 8 weeks after implantation. Semithin plastic sections and electron microcopy 
revealed that cells and axons more rapidly invaded BDNF foam than control foam. Also, BDNF foam contained 
almost twice as many blood vessels than control foam at 8 weeks after implantation. Tissue sparing was similar 
in all three implantation paradigms; approximately 42% of tissue was spared in the rostral cord and 
approximately 37% in the caudal cord at 8 weeks post grafting. The number of myelinated and unmyelinated 
axons was low and not different between the two types of foams. Many more axons were found in the fibrin only 
graft. Serotonergic axons were not found in any of the implants and none of the axons regenerated into the 
caudal spinal cord. The behavioral improvements in the hindlimbs were similar in all groups. These findings 
indicated that foam is well tolerated within the injured spinal cord and that the addition of BDNF promotes cell 
survival and angiogenesis. However, the overall axonal regeneration response is low. Future research should 
explore the use of poly(D,L-lactic acid) foams, with or without axonal growth-promoting factors, seeded with 
Schwann cells to enhance the axonal regeneration and myelination response. 
 





Injury to the adult mammalian spinal cord sets off a process known as secondary injury; a cascade of 
pathophysiological events that results in loss of nervous tissue (secondary tissue loss), neuronal cell death, and 
damage of spinal and supraspinal axonal circuitries [1-3]. In humans, injury-induced tissue loss may result in the 
formation of cavities that often extend across the diameter of the cord leaving only a small rim of spinal white 
matter [4,5]. The lack of spontaneous regeneration of severed axons and the presence of cystic cavities prevent 
the formation of new functional synaptic connections, and, consequently, recovery of lost neurological function. 
Clinically, the prospects are poor. In the USA alone, each year over 10,000 newly injured people are added to the 
total of more than 250,000, which are confined to their wheelchair. 
One approach to promote axonal regeneration in the injured spinal cord, which has been investigated 
extensively, is the grafting of three-dimensional cellular transplants bridging the injury gap or cyst (e.g., 
Schwann cells, peripheral nerves; olfactory ensheathing cells; reviewed by [6-8]). Many of these repair strategies 
limit spinal tissue loss [9,10], promote regeneration/ sparing of spinal and supraspinal axons [9-13], and result in 
some functional recovery [9-18]. 
Due to the ongoing (secondary) tissue loss following an injury, it seems inevitable that repair of the (sub-) 
chronically injured cord will require strategies that include the transplantation of cellular grafts to replace lost 
spinal nervous tissue. Moreover, in cord injuries that have resulted in substantial nervous tissue loss, it may be 
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necessary to implant a tubular guidance scaffold that may be a cellular transplant that reconnects the spinal cord 
stumps. The efficacy of tubular implants in combination with Schwann cells has been widely investigated 
(reviewed by [6,19-21]). Following grafting into the transected spinal cord, a SC bridge contained in a polymer 
tubular scaffold promotes regeneration and myelination of damaged axons [22,23]. Combining a SC graft with a 
neuroprotective agent [24] or growth factors [25-27] enhances the overall axonal growth response. 
In the abovementioned studies, the SC bridge was contained within a non-degradable polyacrylnitril/poly-
vinylchloride (PAN/PVC) scaffold. The presence of such a tubular device is thought to prevent the formation of 
scar tissue, allows for accumulation of axonal growth-promoting molecules, and serves as a protective casing for 
the implant. These properties are especially beneficial early in the regeneration response. However, the presence 
of a non-degradable tubular device may become harmful to the overall regeneration response due to constriction 
of the spinal cord ends or foreign body reaction, which may develop over the long term. For these reasons, the 
efficacy of polymer implants in the injured spinal cord has been explored [28-32]. Our group has focused on the 
use of biodegradable synthetic aliphatic poly(a-hydroxyacids) for spinal cord repair [28,29]. Aliphatic poly(α-
hydroxyacids) have been used repeatedly as guidance channels for regeneration in the peripheral nervous system 
[33]. They are biocompatible and easy to manage [20,28]. 
We demonstrated that poly(D,L-lactic acid) and the breakdown products are compatible with Schwann cell 
proliferation and differentiation in vitro [28]. We subsequently showed that poly(D,L-lactic acid) single-channel 
tubular scaffolds containing Schwann cells implanted into the transected adult rat thoracic spinal cord results in 
axonal regeneration and myelination [29]. However, it was also observed that in time these single-channel 
scaffolds would collapse and that this change in geometry was detrimental to the axonal regeneration response. 
From these results we concluded that the use of a polymer scaffold that retains the appropriate mechanical, 
geometrical and permeability properties over time would be beneficial for the regenerative response. 
We have used poly(D,L-lactic acid) macroporous scaffolds (foams) of which the fabrication and characterization 
were described earlier [34,35]. Earlier, grafting of 14-20 rods made of the same material and embedded in fibrin 
glue containing acidic fibroblast growth factor was shown to promote axonal regeneration [34,35]. For this 
study, foams (diameter 2.6 mm; same as adult rat thoracic spinal cord) were made with or without incorporation 
of the neurotrophic factor, brain-derived neurotrophic factor (BDNF). BDNF was chosen in combination with 
the foam because of its effects on cell survival [36-39] and axonal regeneration [18,27,40-42]. Following 
implantation, we have evaluated the effects of the foams on tissue sparing, neuronal survival, axonal 
regeneration, and behavioral improvements of the hindlimbs in the transected adult rat thoracic spinal cord. 
 
2. Materials and methods 
 
2.1.   Animals 
 
Female Fischer rats (n = 49; 140-160g; Charles River Laboratories, Wilmington, NC) were housed according to 
NIH and USDA guidelines. The Institutional Animal Care and Use Committee of the University of Miami 
approved all animal procedures. For these experiments, female rats were used rather than male rats because of 
the easier maintenance following spinal cord transection. Before surgery, rats were anesthetized with rat cocktail, 
a mixture (0.06 ml/100g body weight) of ketamine (42.8 mg/ml), xylazine 98.6 mg/ml) and ace-promazine (1.4 
mg/ml). The backs were shaved and aseptically prepared with Betadine. Lacrilube ophthalmic ointment 
(Allergen Pharmaceuticals, Irvine, CA) was applied to the eyes to prevent drying and Bicillin (0.02 ml/100 mg 
body weight, 300 U/ml; J. Buck, Inc., Owings Mills, MO) was administered intramuscularly. During surgery the 
animals were kept on a heating pad to maintain the body temperature of 39 ± 0.5°C. 
 
2.2.   Preparation of the poly (α-hydroxyacid) macroporous tubular scaffolds (foam) 
 
One gram of poly(D,L-lactide) PLA (Resomer® R-206; Mn: 50,000, Boehringer-Ingelheim, Germany) and 50 
mg of poly(D,L-lactide-b-ethylene oxide) 4k-4k copolymer (Mn: 10,000, CERM, Liege, Belgium) were 
dissolved in  10 ml dimethylcarbonate (DMC, Acros) and filtered over 0.45 µm: Next, 25 µg BDNF (Promega, 
Madison, WI) was dissolved in 2.5 ml of a filtered BSA solution (2mg/ml). The solution was lyophilized and 
grounded to a fine powder. The BDNF/BSA powder was gently dispersed in 5 ml of the polymer solution in 
DMC within a 50 ml-round bottom flask. This solution was frozen with liquid nitrogen and freeze-dried by 
vacuum sublimation for 72 h at -10°C, for 5h at 0°C, and finally at room temperature until it reached a constant 
weight. The fabrication as well as the in vitro degradation characteristics of the polymer foam was described 
previously [34,35]. Using a metal trephine with an inner diameter of 2.6 mm, 1 cm long rods were cut from the 
polymer foam following the longitudinal direction of the pores. The rods were sterilized by UV exposure under a 
laminar flow for 15min. These sterilized rods were kept at -80°C until use. Just before surgery, the rods were 
thawed, cut into 4 mm long segments, and kept in Dulbecco's Minimal Essential Medium until implantation. 
Control foams were prepared using the same procedure but without addition of BDNF. 
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2.3. Implantation of the biodegradable foam 
 
Following a laminectomy at the T8-9 vertebral level, the dura mater was carefully opened. The exposed spinal 
cord (T9-10 level) was completely transected and 4 mm of tissue removed. All spinal roots visible within the 
transection gap were removed. After hemostasis was achieved, a single 4 mm long rod of foam (diameter of the 
rod is similar as diameter of spinal cord; 2.6 mm) with or without BDNF was implanted in between the rostral 
and caudal spinal cord stumps. The scaffold was embedded in 1 % fibrin glue containing acidic fibroblast growth 
factor (FGF1). The glue contained 1% fibrinogen (Type 1 from human plasma; Sigma), 2% CaCl2, 2% 
gentamicin (Gemini Bioproducts, Inc., Calabasas, CA) 2% aprotinin (Sigma), and FGF1 (2 µg/ml; Sigma). FGF1 
was added to limit additional spinal tissue loss [43,44] and to serve as a soft intermediate between the cord 
stumps and the implant. The injury area was rinsed with sterile saline supplemented with 0.1% gentamicin 
(Sigma). After the overlying muscles and skin were sutured separately, the animals received 10 ml Ringers' 
solution subcuteously. The rats were then placed in warmed cages with food and water readily available. To 
prevent urinary tract infection, Bicillin was administered 3, 6 and 9 days post-surgery. The bladders were 
expressed manually two times a day until voluntary bladder release returned. In case urinary tract infection 
occurred, 0.05 ml Baytril was administered (i.m.) twice a day for 7 days. 
In total, 15 rats received a 1% fibrin only implant (n = 3 for 1 week, n = 3 for 4 weeks, and n = 9 for 8 weeks 
survival), 15 rats received a control foam implant 
(n = 3 for 1 week, n = 3 for 4 weeks, and n = 9 for 8 weeks survival), and 15 rats received a fibrin only implant 
(n = 3 for 1 week, n = 3 for 4 weeks, and n = 9 for 8 weeks survival). 
 
2.4.   Retrograde neuronal tracing 
 
Eight weeks after implantation, the spinal cord distal to the injury/implantation site was re-exposed and a total of 
0.6 ml of a 2% aqueous fast blue solution (FB, Sigma) was injected 7 mm distal to the distal implant-spinal cord 
interface (between vertebrae T10 and T11) using a glass needle (diameter was approximately 150 µm) attached 
to a 1 ml Hamilton syringe. With the help of a micromanipulator, four 0.15 µl injections were made 0.6 mm 
lateral to the dorsal sulcus at 1 and 2 mm deep (bilaterally) into the spinal cord. Each injection was carried out 
over a 3 min period and the needle was kept in place for an additional 3 min after each injection to prevent 
leakage of the tracer during withdrawal of the needle. After the injections, the muscle layers were closed 
separately, the skin closed with metal wound clips and the rat returned to her cage. 
 
2.5.   Assessment of behavioral performance 
 
In rats that survived for 8 weeks, changes in hindlimb function were assessed using the Basso, Beattie, and 
Bresnahan-test (BBB-test [67,68]), an open field test with a 21-point scale. The BBB-test distinguishes between 
movements of individual components of the hindlimb. During the week before surgery the rats were tested twice 
to become accustomed to the test and the testing environment. During survival after surgery, rats were tested 
once a week for 4 min by two independent observers who were oblivious of the experimental paradigms. 
 
2.6.   Histological procedures 
 
Two, 4, and 8 weeks after implantation, animals were deeply anesthetized with rat cocktail [0.06 ml/100 g body 
weight; ketamine (42.8 mg/ml), xylazine 98.6 mg/ml) and acepromazine (1.4 mg/ml)] and perfused 
transcardially with 150 ml heparinized saline followed by 400 ml of 4% PFA in PB (0.1 M, pH 7.4). The spinal 
cord was removed and post-fixed overnight in the same fixative at 4°C. Next, the grafted area including 5 mm of 
the proximal and caudal spinal cord was dissected out and transferred to phosphate-buffered 30% sucrose except 
for a 1-mm thick section taken from the middle of the implant. This section was transferred to 2% glutaraldehyde 
with 3% sucrose in PB for at least 24 h at 4°C, processed for plastic embedding, and then cut transversally (1 µm 
thick) on a Reichert-Jung ultra-microtome. These sections were stained with a  1% toluidine blue-1% methylene 
blue-1 % sodium borate solution and used to analyze the tissue cable histology and to determine the number of 
myelinated axons and blood vessels in the implants. Of 2 animals of each group, ultra-thin transversal sections of 
the 1 mm tissue block were cut, stained with uranyl acetate and lead citrate, and examined with a Philips CM-10 
transmission electron microscope. 
The other tissue blocks were embedded in Tissue-Tek O.C.T. compound (Miles Laboratories) and cut 
longitudinally/horizontally on a cryostat. The 20 µm thick sections were collected on gelatin-coated glass slides 
and stored at 4°C until immunohistochemical and cresyl violet staining. 
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2.7.   Immunostaining 
 
Cryostat sections were permeabilized with 0.3% Triton X-100 in phosphate-buffered saline (PBS; 0.1 m, pH = 
7.4) and then immuno-blocked with 10% normal goat serum in PBS at room temperature for 30min. Next, the 
sections were incubated overnight with the primary antibody diluted in PBS containing 10% NGS and 0.3% 
Triton X-100 in humidified boxes at 4°C. The following primary antibodies were used: polyclonal rabbit 
antibodies against glial fibrillary acidic protein (GFAP, 1:200; Incstar Corp., Stillwater, MN), S100 (1:200; 
Dakocorps, Carpinteria, CA), laminin (1:400, Sigma), serotonin (5-HT, 1:100; Incstar Corp.), and monoclonal 
antibodies directed against neurofilaments (NF; RT97, 1:5; Developmental Hybridoma bank), 
monocytes/macrophages (ED1; MCA341, 1:500; Sero-tec, Oxford, UK), chondroitin sulfate (CS-56, 1:100; 
Sigma), and neuronal nuclear-specific protein (NeuN [45]; MAB377, 1:100; Chemicon, Temecula, CA). Next, 
the sections were rinsed in PBS and incubated with fluorescein-conjugated goat anti-rabbit (1:200; Cappel/ 
Organ on Teknika Corp., Durham, NY) or rhodamine-conjugated goat anti-mouse (1:100; Cappel/Organon 
Teknika Corp.) antibodies at room temperature for 1 h. Finally, the sections were washed with PBS, cover-
slipped with Cityfluor (UKC Chem. Lab., Canterbury, UK) and kept at 4° C until analysis. Adjacent sections 
were stained for cresyl violet. 
 
2.8.   Assessment of spared spinal tissue 
 
At 2, 4, and 8 weeks after implantation, the amount of spared spinal tissue in a 2 mm long cord segment adjacent 
to the rostral and caudal interface was determined in a blinded fashion in cresyl violet-stained 20 µm thick 
horizontal cryostat sections. Using an image analysis system (Universal Imaging, West Chester, PA, USA), the 








’) was determined in an average of 10 sections at 200 
µm intervals extending the width of the cord. Infiltrated tissue was delineated by a noticeable change in the 
density of infiltrating small cells, which resembled neutrophils and lymphocytes, and the presence of healthy 
neurons, which were recognized by darkly stained Nissl bodies in their cytoplasm. Lost tissue (cavities) was 
easily recognized by the lack of tissue. The single measurement from all sections were summed and multiplied 
by 10 (every tenth section was analyzed) to give the total area of damaged tissue. The total volume of the area of 
damaged tissue was derived by means of numerical integration. This volume of damaged tissue was then 
subtracted from the volume of the 2 mm long segment of the spinal cord adjacent to the rostral and caudal cord-
graft interface to determine the volume of the remaining healthy appearing spinal cord tissue (spared tissue). 
Finally, these numbers were expressed as the percentage of the mean volume of a 2 mm long cord segment (T9 
level) from four normal uninjured rats. 
 
2.9.   Quantification of the number of NeuN-positive cells at the spinal cord-implant interfaces 
 
The number of NeuN-positive cells was determined in a 200 µm wide area located 0.5 mm from the graft-host 
cord interface in every tenth sections of the rostral and distal cord. The sections were examined under 
fluorescence microscopy using a 63 x objective. In addition, the number of NeuN-positive cells was determined 
in a comparable area in a normal, uninjured spinal cord (n = 3). The average number of NeuN-positive cells 
found in the injured/transplanted cords was expressed as a percentage of the average number found in the 
uninjured spinal cord. 
 
2.10.   Quantification of the number of blood vessels and myelinated axons in the implant 
 
Transversal, semithin, toluidine blue-stained plastic sections were used to determine the number of blood vessels 
and myelinated axons at the midpoint of the implants. The sections were examined under light microscopy using 
a 63 x objective by moving a square grid (surface area: 0.028 mm
2
) from left to right and from top to bottom 
through the whole transverse section of the implants. Every blood vessel and every myelinated axon present 
within the confines of the grid were counted before the grid was moved to the next position. 
 
2.11.   Statistical analysis 
 
One-way analysis of variance (ANOVA) followed by Fisher's protected least-significant difference (PLSD) test 
was used to determine statistical differences between the average number of axons and neurons as determined for 
each group. However, in case of unequal variance (F test), a nonparametric analysis (Kruskal-Wallis test 
followed by Mann-Whitney U-test) was used. The latter test was also used to determine whether differences 
between the average BBB score per group were statistically significant. A statistically significant difference was 
accepted at p < 0.05. 
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Scanning electron microscopy revealed the longitudinal orientation of the pores along the cooling direction in the 
poly(D,L-lactic acid) foam (Fig. 1a). In a transverse section of the foam, macropores as well as micropores (with 
a diameter of 10mm or less) could be observed (Fig. 1b). Although few large macropores of >300 µm in 
diameter were present, in general the diameter varied between 75 and 200 µm: The macro-pores were connected 
to each other by a network of micropores. There were no obvious differences between the control and BDNF-
foams. 
 
Fig. 1. Poly(D,L-lactic acid) foam contained pores oriented along the cooling direction. Scanning electron 
microscopy images of the foam, (a) Longitudinal section. asterisks are placed in some of the macropores, and 
(b) transversal section. asterisks are placed within two of the larger macropores (> 300 µm). 
 
3.2.   Morphology and histology of the implants 
 
Transverse sections of the middle of the implants stained with toluidine blue revealed that cells had migrated into 
the periphery of the foams at 2 weeks after implantation, whereas the core of the foams contained only a few 
cells (Fig. 2a and b). A few layers of fibroblasts surrounded the foams (Fig. 2b) and blood vessels were present 
throughout the periphery of the foams. Sporadically a myelinated axons was observed (see below). Electron 
microscopy demonstrated the presence of fibroblasts, meningeal cells, Schwann cells (Fig. 2c), and a few 
macrophages. Fibrin and collagen fibrils were present especially in the cellular area at the periphery (Fig. 2c). 
Electron microscopy also revealed the presence of a sporadic unmyelinated axons (Fig. 2c). There was no 
difference in morphology and histology between the control foam and the BDNF-foam except that the BDNF 
foam contained more axons. The fibrin only implant at 2 weeks after implantation also contained most of the 
migrated cells in the periphery but many had also migrated into the core (Fig. 2d). The fibrin only implant was 
surrounded by several layers of fibroblasts (Fig. 2d). Fibrin and collagen fibrils, myelinated (Fig. 2e) and 
unmyelinated axons (Fig. 2f) were present throughout the implant. 
At 4 weeks, more cells had migrated into the control foam, but the core was still not fully occupied (Fig. 2g). In 
contrast, by this time, the BDNF-foams were completely invaded by cells (Fig. 2h). Blood vessels were present 
throughout the foams. Very few myelinated axons were observed (see below). Electron microscopy revealed the 
presence of collagen fibrils in the cellular areas of both types of foam (Fig. 2i). Unmyelinated axons were present 
throughout both types of implants (Fig. 2i). At this time point, the fibrin only implant was largely similar to the 
fibrin implant at 2 weeks post implantation, although more cells had migrated into the core. Cells, collagen 
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fibrils, myelinated and unmyelinated axons were present throughout the implant. 
At 8 weeks after implantation, both types of foam were now completely invaded by cells (Fig. 2j). The implants 
contained blood vessels (Fig. 2k). Myelinated axons were rarely found (see below). Electron microscopy 
revealed the presence of collagen fibrils and unmyelinated axons throughout the foams (Fig. 2l). There were no 
apparent differences between the two types of implants. The 8-week old fibrin only implants contained cells, 
fibrin and collagen fibrils, myelinated and unmyelinated axons. 
 
3.3.   Host spinal cord-implant interface 
 
In all animals, some small cavities were present in the spinal tissue close to the implant-cord interface at 2 weeks 
after implantation (Fig. 3a). At 4 and 8 weeks after implantation, more and larger cavities were visible in the 
spinal cord tissue near the interface (Fig. 3b). There was no apparent difference in number or size of the cavities 
between animals that received the control or BDNF-foam with fibrin and animals that received fibrin only. At all 
time points, GFAP-positive reactive astrocytes were found in the spinal cord-implant border (Fig. 3c). At 4 and 8 
weeks after implantation, some GFAP immunoreactivity was found within the control and BDNF foam (Fig. 3d). 
Some ED1-positive microglia/macrophages were found in the host spinal cord near the interface and in the 
implant at all time points. The distribution of the GFAP- and ED1-immunoreactivity was similar to that seen in 
other complete transection/transplantation paradigms, suggesting that the poly(D,L-lactic acid) foam did not 
provoked a gliotic and inflammatory response beyond what is normally seen [29]. Lamimin-positive blood 
vessels were found at the cord-implant interface and in the foam at all time points (Fig. 3e). More blood vessels 
were present in the BDNF foam at the longer survival time (see below). Chondroitin sulfate proteoglycan 
(CSPG) was expressed in the spinal tissue near the interface and in the foams where it appeared to be co-
localized with laminin-positive blood vessels (Fig. 3f). 
 
 
Fig. 2. Morphology and histology of the implants. (a) Transverse toluidine blue-stained semithin section through 
the midst of control foam 2 weeks after implantation. Note that cells have invaded the periphery but not the core 
of the foam, (b) Enlargement of the outlined area in (a). Arrows point at the fibroblast layers surrounding the 
foam, (c) Electron micrograph demonstrating the presence of a Schwann cell (SC) and an ensheated axon (A) in 
control foam 2 weeks after implantation. Asterisks indicate the presence of collagen fibrils. Arrow points at 
basal lamina, (d) Transverse toluidine blue-stained semithin section through the midst of a fibrin only implant 2 
weeks after implantation. Note that more cells have invaded the core of the implant compared to control foam in 
(a). Arrows point at the fibroblast layers surrounding the implant. Star is placed in a blood vessel, (e) Outlined 
area in (d) showing myelinated axons and blood vessels (star) in the fibrin only implant, (f) Electron micrograph 
demonstrating the presence of a Schwann cell (SC), myelinated axons (MA), and unmyelinated axons (A) in a 
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fibrin only implant 2 weeks after implantation, (g) Transverse toluidine blue-stained semithin section through the 
midst of control foam 4 weeks after implantation. (h) Transverse toluidine blue-stained semithin section through 
the midst of BDNF foam 4 weeks after implantation. Note difference with control foam in (g); more cells have 
migrated into the core of the foam at this time point, (i) Electron micrograph showing a Schwann cell (SC) and 
an ensheated axon (A) in BDNF foam 4 weeks after implantation. Asterisks indicate collagen fibrils. The arrow 
points at basal lamina. (j) Transverse toluidine blue-stained semithin section through the midst of control foam 8 
weeks after implantation. (k) Transverse toluidine blue-stained semithin section demonstrating the presence of 
blood vessels in control foam at 8 weeks after implantation, (l) Electron micrograph demonstrating the presence 
of an ensheated axon (A) in BDNF foam 4 weeks after implantation. Asterisks indicate collagen fibrils and the 




3.4.  Tissue sparing was similar in all three paradigms 
 





’; Fig. 4a). In addition, close to the implant in gray as well as white matter we observed areas that were 




’; Fig. 4b), 
which were devoid of healthy looking neuronal cell bodies (as analyzed using morphological criteria). The area 





The amount of spared spinal nervous tissue was determined in a 2 mm long segment of the spinal cord adjacent 
to the rostral and caudal cord-implant interface at 2, 4, and 8 weeks after implantation. First, the mean total 
volume of damaged tissue was determined, which was then subtracted from the mean volume of the analyzed 
segment to give the mean volume of spared tissue. This value was then expressed as the percentage of the mean 
volume of a comparable 2 mm long spinal cord segment at the T9 level in normal, uninjured, Fischer rats, which 
was 10.7 ± 0.82 mm
3
 (SEM, n = 4). In animals that received fibrin only, the volume of spared spinal tissue in the 
rostral cord stump was 75.4 ± 7.5% (SEM, n = 6), 52.3 ± 6.9%, and 44.2 ± 6.1% at 2, 4, and 8 weeks after 
implantation, respectively, of the volume in a normal uninjured rat (Fig. 4c). The volume of spared tissue in the 
rostral cord in rats with control foam was 77.6 ± 8.7% (SEM, n = 7), 50.1 ± 5.8%, and 42.2 ± 7.5%, and in rats 
with BDNF foam,   78.3 ± 6.3%   (SEM,   n = 6),   54.7 ± 7.2%,   and 43.2 ± 8.2% at 2, 4, and 8 weeks post-
implantation, respectively, of the volume in a normal animal (Fig. 4c). In the caudal cord the volume of spared 
tissue (as a percentage of the volume in a normal, uninjured cord) in rats with fibrin only was 73.4 ± 7.1% (SEM, 
n = 6), 48.3 ± 7.4%, and 38.2 ± 8.8%, in rats with control foam, 71.3 ± 6.4%   (SEM,  n = 7),  44.4 ± 6.7%,  and  
39.3 ± 7.5%,   and  in  rats   with   BDNF   foam,   73.1 ± 7.2% (SEM, n = 6), 48.7 ± 6.6%, and 37.8 ± 6.8% at 2, 
4, and 8 weeks post-implantation, respectively (Fig. 4d). This result demonstrate that a complete transection 
followed by implantation of fibrin only or foam results in substantial loss of spinal nervous tissue; up to 58% in 
the rostral cord and up to 63% in the caudal cord. In addition, implantation of foam with or without BDNF 
compared to fibrin only does not result in further loss of spinal nervous tissue. 
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Fig. 3. Poly(D,L-lactic acid) foam were well integrated in the injured spinal cord. (a) Horizontal cresyl violet-
stained section demonstrating the presence of small cavities in the spinal cord near the interface with the foam 
(F) 2 weeks after implantation. Asterisks are placed within the cavities, (b) Same as (a) but showing a larger 
cavity near the cord-foam (F) interface 4 weeks after implantation. Asterisk is placed within the cavity, (c) 
GFAP-positive cells and processes in the spinal cord, but not in the foam (F), at 2 weeks after implantation. 
Asterisks placed in cavities in spinal cord, (d) GFAP-positive processes (arrows) in control foam (F) at 4 weeks 
after implantation. Asterisk indicates a cavity in the spinal cord, (e) Laminin-positive profiles in BDNF foam (F) 
8 weeks after implantation, (f) Same area as in (e) but demonstrating CSPG-immunoreactive profiles in BDNF 
foam (F). Note the apparent colocalization of laminin and CSPG. Asterisks are placed in cavities in the spinal 
cord. Bar represents 600 µm (a, b) and 150 µm (c-f). 
 
3.5. Foams with BDNF promoted neuronal survival in the rostral spinal cord 
 
The number of NeuN-positive cells was quantified in the rostral and caudal stump in a 200 µm wide area located 
0.5 mm from the cord-implant interface at 2, 4 and 8 weeks after implantation. NeuN-positive cells in the rostral 
spinal cord at 8 weeks after implantation of control foam and in a normal uninjured spinal cord are depicted in 
Fig. 5a and b, respectively. At 4 and 8 weeks, but not at 2 weeks, implantation of BDNF foam resulted in a 
significantly (p<0:05) higher number of NeuN-positive cells in the rostral but not in the caudal spinal cord 
compared to control foams or fibrin only. When the numbers were expressed as a percentage of the number 
found in comparable levels in the normal, uninjured spinal cord, implantation of fibrin only resulted in survival 
of 72.7 ± 9.7% (SEM; n = 6), 42.9 ± 7.3%, and 21.9 ± 6.4%, in the rostral cord at 2, 4, and 8 weeks after 
implantation, respectively (Fig. 5c). With control foam (n = 5) neuronal survival in the rostral cord was 75.± 
79.1%, 39.5 ± 6.8%, and 19.2 ± 7.4%,     and     with     BDNF     foam     (n = 7); 73.4 ± 8.2%, 60.6 ± 6.2%, and 
42.2 ± 7.5% at 2, 4, and 8   weeks   after   implantation,   respectively   (Fig.   5c). Neuronal survival in the 
caudal cord was 63.3 ± 6.2% (SEM; n = 6), 35.2 ± 7.3%, and 17.3 ± 8.9% with fibrin only, 60.8 ± 7.8%, 40.4 ± 
7.8%, and 19.9 ± 10.4% with control foam (n = 5); and 66.5 ± 7.5%, 39.2 ± 9.9%, and 23.4 ± 9.1% with BDNF 
foam ðn ¼ 7); at 2, 4, and 8 weeks after implantation, respectively (Fig. 5d). These results indicate that in this 
transection/implantation paradigm addition of BDNF to the foam promotes cell survival near the rostral spinal 
cord-implant interface at 4 and 8 weeks after implantation. 
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Fig. 4. All implants resulted in similar sparing of spinal cord tissue. (a) Horizontal cresyl violet-stained section 
demonstrating the presence of several small cavities in the spinal cord near the interface with the foam (F) 2 
weeks after implantation. Asterisks are placed within the cavities, (b) Horizontal cresyl violet-stained section 
demonstrating the presence of an area (outlined) near the cord-foam (F) interface infiltrated with many small 
cells at 2 weeks after implantation, (c) Bar graph demonstrating tissue sparing (as % of normal cord) in the 
rostral cord at 2, 4, and 8 weeks after implantation of fibrin only, control foam, and BDNF foam, (d) Bar graph 
demonstrating tissue sparing (as % of normal cord) in the caudal cord at 2, 4, and 8 weeks after implantation of 
fibrin only, control foam, BDNF foam. Bar represents 500 µm (a, b). 
 
 
Fig. 5. BDNF containing foam increased neuronal survival in the rostral spinal cord at 4 and 8 weeks after 
implantation. (a) Horizontal section showing NeuN-positive cells (neurons) in the gray matter 0.5 mm from the 
rostral cord—foam interface 2 weeks after implantation, (b) Horizontal section showing NeuN-positive neurons 
in gray matter at a comparable level as in (a) in the normal, uninjured spinal cord, (c) Bar graph demonstrating 
the number of NeuN-positive cells (as % of normal cord) in the rostral cord at 2, 4, and 8 weeks after 
implantation of fibrin only, control foam, and BDNF foam. Cells were counted in a 200 µm wide strip of tissue 
0.5 mm away from the rostral cord-implant interface. Asterisk indicates a significant difference (p<0.05) with 
fibrin only and control foam groups. (d) Bar graph demonstrating the number of NeuN-positive cells (as % of 
normal cord) in the caudal cord at 2, 4, and 8 weeks after implantation of fibrin only, control foam, BDNF foam. 
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Cells were counted in a 200 µm wide strip of tissue 0.5 mm away from the caudal cord-implant interface. Bar 
represents 35 µm (a, b). 
 
 
Fig. 6. NF-positive axons were present in the foam. (a) Horizontal section showing NF-positive axons in the 
spinal tissue but not in control foam (F) at 2 weeks after implantation, (b) Horizontal section showing NF-
positive axons within control foam (F) at 4 weeks after implantation. (c) Bar graph demonstrating the average 
number ( ± SEM) of myelinated axons within the midst of the fibrin only, control foam, and BDNF foam at 2, 4, 
and 8 weeks after implantation. Asterisk indicates a significant difference (p<0.01) with both foam groups. Bar 
represents 200µm (a) and 50µm (b). 
 
3.6. Axons regenerated into the implants 
 
NF-positive axons were found within the fibrin only implant at all time points after implantation. Control foams 
did not contain NF-positive axons at 2 weeks after implantation (Fig. 6a). However, at 4 and 8 weeks after 
implantation NF-positive fibers (single or in small bundles) were observed within the foams (Fig. 6b). In 
contrast, in BDNF-foams, NF-positive axons were found at 2, 4, and 8 weeks after transplantation. These 
findings indicate that the addition of BDNF to the foam resulted in an earlier ingrowth of axons into the implant. 
Axons positive for 5-HT were not found within any of the implants, suggesting that the responding axons were 
not of serotonergic origin. 
The number of myelinated axons in the implants was determined in 1-µm thick transverse sections taken from 
the middle of the implant. In animals that received fibrin only, 113 ± 20 (average ± SEM; n = 3) were present 2 
weeks after implantation, 121 ± 18 (n = 3) at 4 weeks and 204 ± 46 (n = 3) at 8 weeks (Fig. 6c). In control foam, 
4 ± 2 (n = 3) were present 2 weeks after implantation, 8.3 ± 2.3 (n = 3) at 4 weeks and 5.5 ± 0.5 (n = 3) at 8 
weeks (Fig. 6c). In animals that received foams with BDNF, 3.3 ± 1.2 myelinated axons (n = 3) were present at 2 
weeks, 8 ± 1.2 (n = 3) at 4 weeks, and 7 ± 1 (n = 3) at 8 weeks (Fig. 6c). There was a statistical difference 
between the numbers of myelinated axons within the fibrin only and both foam implants at all time points 
(p<0.01). There were no statistical differences between the numbers of myelinated axons within the control and 
BDNF-foams at any time point. Clearly, the implantation of foam with or without BDNF does not result in 
substantial myelination of regenerating axons. 
 
3.7. Foams with BDNF improved angiogenesis 
 
Immunostaining for laminin revealed the presence of blood vessels within the implants at all time points studied 
(see Fig. 7a and b; see also Fig. 3e). In toluidine blue-stained sections, blood vessels could be readily identified 
in the implants at all time points (see also Fig. 2k). The number of blood vessels in the implants was determined 
in a 1 µm-thick transverse section taken from the middle of the implant. In animals that received fibrin only, 65 ± 
11 (average ± SEM; n ¼ 3) blood vessels were present at 2 weeks, 96 ± 7 (n  3) at 4 weeks, and 137 ± 9 (n = 2) 
at 8 weeks post-grafting (Fig. 7c). In animals that received control foam, 18 ± 1 (average 7 SEM; n = 3) blood 
vessels were present at 2 weeks, 23 ± 2.3 (n = 2) at 4 weeks, and 31 ± 1.5 (n = 3) at 8 weeks post-grafting (Fig. 
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7c). In BDNF-foams, 22 ± 4.3 ðn ¼ 3Þ blood vessels were present at 2 weeks after implantation, 24.7 ± 1.9 (n = 
3) at 4 weeks, and 58 ± 4 (n = 3) at 8 weeks (Fig. 7c). At all time points, there was a statistical difference 
between the number of blood vessels in the fibrin only and the two foam groups (p<0.01): Also, there was a 
statistical difference between the numbers of blood vessels found in the BDNF-foam and the control foam 
(p<0.05) at the 8-week time point. 
 
 
Fig. 7. BDNF promoted the formation of blood vessels in the foam. (a) Laminin-positive profiles in BDNF foam 
(F) at 4 weeks after implantation, (b) Laminin-positive profiles in BDNF foam (F) at 8 weeks after implantation, 
(c) Bar graph demonstrating the average number ( ± SEM) of blood vessels within the midst of the fibrin only, 
control foam, and BDNF foam at 2, 4, and 8 weeks after implantation. Double asterisks indicate a significant 
difference (P<0:01) with both foam groups. Single asterisk indicates a significant difference (p<0.05) between 
the BDNF and control foam group. Bar represents 150 µm (a, b). 
 
3.8.   Axons did not regenerate into the distal spinal cord 
 
Axonal regeneration across the fibrin only or foam implants and into the distal spinal cord was examined using 
retrograde FB neuronal tracing. In none of the animals retrogradely labeled neurons were found in the rostral 
spinal cord or brain, suggesting that axons were not regenerating from the implant into the distal spinal cord. 
 
3.9.   Implants did not improve hindlimb performance 
 
All animals exhibited a gradual improvement in hindlimb locomotor function during the 8 weeks following 
implantation. Animals that received fibrin only reached a score of 5.8 ± 0.6 (average ± SEM) at 8 weeks after 
implantation (Fig. 8). Animal with a control foam reached 5.7 ± 0.6 and with a BDNF-foam, 6.5 ± 0.2 at 8 weeks 
post grafting (Fig. 8). The BBB score of approximately 6 implies extensive movement of two hindlimb joints. 
 
 
Fig. 8. Functional recovery of the hindlimbs was similar in all three implantation paradigms. Bar graph 
Published in: Biomaterials (2004), vol. 25, iss. 9, pp. 1569-1582 
Status: Postprint (Author’s version) 
demonstrating the average ( ± SEM) BBB scores during the 8 weeks of survival after implantation of fibrin only, 





In the present study we have explored the use of biodegradable macroporous guidance channels with or without 
BDNF in the completely transected adult rat spinal cord. The complete transection model has been used 
extensively over the last decade to explore the ability of cellular and non-cellular implants to promote axonal 
regeneration and functional recovery following spinal cord injury. This model is especially suitable because the 
axonal response is unquestionably due to regeneration, which allows for a clear interpretation of the ability of 
cells, materials, and growth factors to promote axonal regeneration in the injured spinal cord. 
Implantation of foam with BDNF had a neuroprotective effect on neurons in the rostral but not caudal spinal 
cord. We found that up to 20% more NeuN-positive cells a short distance away from the rostral cord-implant 
interface survived at 8 weeks after implantation of the BDNF-foam compared with control foam and fibrin only. 
Following injury to the adult cord, (active) apoptotic and (passive) necrotic mechanisms contribute to cell death 
[46,47]. It has been shown previously that BDNF can rescue neurons from injury-induced death [36-39]. BDNF 
may exerts this neuroprotective effects through calmodulin [48,49]. BDNF may also be involved in the 
suppression of injury-induced delayed apoptosis [50], possibly through the increase of the antiapoptotic 
molecule, Bcl-xl [51]. An alternative mechanism for the neuroprotective effect of BDNF could be a BDNF-
regulated reduction of the number of terminal clubs formed at the distal axonal stumps in the rostral cord [52]. 
Terminal clubs are formed by continuous anterograde axonal transport after transection and sealing of the axon 
[53] and contain hydrolytic enzymes that contribute to nervous tissue loss [1,2,54]. This possible mechanism 
seems less likely because the amount of tissue loss was similar in all three implantation paradigms. 
The effect of BDNF on survival of NeuN-positive cells was visible at 4 and 8 weeks after implantation, which 
may reflect the onset of degradation of the poly(D,L-lactic acid) foam. The poly(D,L-lactic acid) foam used in 
the present study contained PLA-b-poly(ethylene oxide) 4k-4k copolymer, which increases the absorption of 
water, e.g., the wettability of the foam [34]. However, it is difficult to foretell the in vivo degradation time of the 
polymer foam because it depends on the size, shape, and porosity of the foam, and the variability of the in vivo 
milieu, e.g., the injured adult spinal cord. 
The finding that BDNF did not exert a neuroprotective effect in the caudal spinal cord stump may reflect 
differences between the rostral and caudal cord following transection and/or transplantation (see [55]). Here, the 
finding that BDNF did not influence neurons in the caudal stump may reflect differences in injury-induced 
damage to the blood supply to the caudal and rostral spinal cord stumps [56-59]. Possibly, the reduced blood 
flow has resulted in a diminished supply of oxygen and nutrients, which would result in an increased cell death 
(reviewed by [3]). Alternatively, the diminished blood flow may have prevented the supply of BDNF from the 
degrading foam to the caudal stump in high enough levels to promote an effect on neuronal survival. 
The implantation of foam containing BDNF increased the number of blood vessels at the mid-level of the 
implant compared to the control foam at 8 weeks after implantation. Blood vessels are formed by endothelial 
cells, which produce and secrete BDNF [60]. Also, BNDF is a known survival factor for endothelial cells, which 
express the trkB receptor [61]. Possibly, BDNF released from the implanted poly(D,L-lactic acid) foam has 
resulted in an increased number or in an increased proliferation of endothelial cells, which has resulted in the 
formation of a higher number of blood vessels. However, an effect of BDNF on endothelial cell migration and 
proliferation has not been demonstrated unambiguously in the injured adult rat spinal cord. The presence of 
FGF1 in the fibrin glue may also have contributed to the formation of blood vessels [62], which may explain the 
much higher numbers found in the fibrin glue only implant. 
Tissue sparing at the rostral and caudal interface was similar in all groups. More tissue albeit not significantly 
was lost in the caudal stump compared with the rostral stump. It should be noticed that the total amount of tissue 
loss within both cord stumps was approximately 60% in the rostral and 65% in the caudal cord stump. The 
presence of fibrin glue with FGF1 may have contributed to the sparing of spinal nervous tissue. The rationale to 
embed the poly(D,L-lactic acid) foam within fibrin glue was to prevent possible abrasion of the vulnerable 
damaged spinal cord stump by the somewhat sturdy foam. In addition, the fibrin glue may serve as a structural 
support for the implant and as an adhesive medium for the implant and the spinal cord stump [63]. Also, FGF1 
was added to the fibrin glue because it was shown to promote axonal regeneration and reduce neuronal death 
[11] and reduce axonal dieback [64]. Previous studies using rat models have demonstrated the important role of 
FGF1 in axonal regeneration in the injured adult spinal cord [11,64,65]. 
The number of NF-positive axons within both types of poly(D,L-lactic acid) foams was low compared with 
fibrin only implants, suggesting that the porous polymer structure supported only limited axonal ingrowth. One 
possible explanation for the low number of regenerating axons within the foam could be the lack of 
interconnected macropores. However, earlier it has been demonstrated, using impedance spectroscopy that relies 
Published in: Biomaterials (2004), vol. 25, iss. 9, pp. 1569-1582 
Status: Postprint (Author’s version) 
upon measuring the ionic conduction of water-saturated foams, that the foams as used within the present study 
were highly porous and open on an interconnecting network of micropores [66]. In fact, the three-dimensional 
porous foams demonstrated adequate transport properties, which reflect a high pore interconnectivity [66]. 
Besides a low number of axons, the number of myelinated axons in the foams was also low compared to fibrin 
only implants. Overall, compared to both types of foam, a fibrin only implant resulted in a much better axonal 
regeneration response. This may reflect the fact 
that a fibrin only implant attracts a much higher number of Schwann cells than a foam implant. Using electron 
microscopy, some Schwann cells were found within the foams at all time points. Also, some of the Schwann 
cells in the foams were found to ensheath axons. Clearly, the polymer foam did not support the invasion of a 
high number of Schwann cells. Earlier, implantation of 14-20 rods, made of the same material as the foams in 
the present study, in between the cord stumps and embedded in fibrin glue with FGF1 following a complete 
transection of the adult thoracic spinal cord did promote axonal regeneration into the transplanted lesion site 
[34,35]. The difference with the present study may be that more fibrin glue with FGF1 will be present in between 
the small rods, which may result in a much better axonal growth response than with fibrin only in between the 
foam and the cord stumps. 
BDNF containing foam results in a more rapid ingrowth of axons. Axons were present in BDNF-foam at 2 
weeks after implantation, whereas at this time point control foam was lacking axons. Previously, BDNF has been 
shown to promote axonal regeneration into and from intraspinal grafts [18,25,27,40-42]. Clearly, the more rapid 
growth of axons into the BDNF containing foam may have resulted from the axonal growth-promoting 
properties of BDNF. 
With retrograde tracing techniques we demonstrated that none of the axons within the foam grew into the caudal 
spinal cord in any of the three paradigms. This finding explains the lack of substantial hind limb functional 
improvements. In all three implantation paradigms the observed average improvements in hind limb function 
were largely similar. The BBB score was approximately 6, which implies extensive movement of two hindlimb 
joints. Our results demonstrate that the presence of the polymer foam did not hinder functional improvements 
seen normally after a complete spinal cord transection. Also, the presence of the BDNF containing foam did not 
enhance functional recovery compared to the control foam. Ideally, for a more substantial and biological 
significant improvement of hind limb function in the injured and implanted adult rat spinal cord, descending 
axons, which are involved in locomotor function, have to regenerate across the implant and into the caudal cord 
where they need to form synaptic connections with target neurons. 
In summary, our results demonstrated that poly(D,L-lactic acid) scaffolds are well tolerated in the transected 
adult rat spinal cord. The gliotic and inflammatory response is not beyond what is normally seen after 
transection/implantation in the cord and the amount of tissue loss is similar after implantation of foam or fibrin 
only. Moreover, the presence of BDNF in the foam has a neuroprotective effect on neurons in the rostral cord, 
results in a more rapid ingrowth of axons and in the formation  of blood  vessels  in  the  foam.  However, despite 
these effects, the overall axonal regenerative response is low and none of the responding axons grew from the 
foam into the caudal cord. Responsible for the low axonal growth response may be the limited presence of 
Schwann cells within the foam. The seeding of Schwann cells into the foam before implantation may result in an 
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